Target intelligence / Profile preview

ACTB pseudogene 14 (ACTBP14)

Target: ACTBP14
Molecular classification: Other (Pseudogene)

Overview

ACTB pseudogene 14 (ACTBP14) is classified as a pseudogene derived from the beta-actin gene (ACTB). Pseudogenes are genomic DNA sequences similar to normal genes but are typically nonfunctional; they arise from gene duplications or retrotranspositions and generally do not code for functional proteins. ACTBP14 does not contribute to cellular processes and is not implicated in human disease or drug action. It is one of many ACTB pseudogenes dispersed throughout the human genome, reflecting evolutionary remnants of gene duplication events[6][4].

Other names: actin, beta pseudogene 14ACTBP14

Beyond the preview

Go deeper on ACTB pseudogene 14 (ACTBP14).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ACTB pseudogene 14 (ACTBP14).

Explore the full profile